Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05100654 · ClinicalTrials.gov registry record · Early Phase 1
Collaborative Urological Prosthetics Investigation Directive Research Group
A Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection, sponsored by University of Chicago.
- Active
- Registry status
- Early Phase 1
- Development phase
- 800
- Enrollment target
- 1
- Study location
NCT05100654: Active Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection, sponsored by University of Chicago.
NCT05100654 is a Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 800 participants, above the 207-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (286% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05100654, a Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if an additional 6 days of oral antibiotics decreases the risk of penile prosthesis infection after implantation.
Primary Outcome
From day of surgery through 1 year we are hoping to show that additional 6 days of oral antibiotics do not decrease the risk of penile prosthesis infection requiring surgical intervention for device removal.
Conditions Studied
Interventions
- DRUG Ciprofloxacin
- DRUG Doxycycline
- DRUG Augmentin
- DRUG Bactrim
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2028-01-01 |
| Phase | Early Phase 1 |
What the registry record for NCT05100654 still lists
NCT05100654 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 207-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (286% higher).
The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 4 interventions - of which Ciprofloxacin is the first listed.
NCT05100654 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05100654 about?
NCT05100654 is a clinical study titled "Collaborative Urological Prosthetics Investigation Directive Research Group". The purpose of this study is to determine if an additional 6 days of oral antibiotics decreases the risk of penile prosthesis infection after implantation.
What is the current status of trial NCT05100654?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 800 participants. The study started on 2022-04-22. Estimated completion is 2028-01-01.
What conditions does trial NCT05100654 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Penile Prosthesis Infection.
What interventions are being tested in trial NCT05100654?
The interventions under investigation include: Ciprofloxacin (DRUG), Doxycycline (DRUG), Augmentin (DRUG), Bactrim (DRUG).
Who is sponsoring clinical trial NCT05100654?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05100654 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05100654's enrollment target sits among peer trials
800 2nd of 33 the highest of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RECRUITING · Phase 3
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI